Notice of Full Year Results
Optima Health plc
("Optima", the "Company", and, together with its subsidiaries, the "Group")
Notice of Full Year Results
LONDON, UK, 10 August 2026, Optima Health (AIM: OPT), the UK's leading provider of technology enabled corporate health and wellbeing solutions, will announce its unaudited results for the Full Year ended 31 March 2026 on Monday 17 August 2026.
Jonathan Thomas, Chief Executive Officer and Andrew Bones, Interim Chief Financial Officer, will host a live virtual analyst briefing at 11:00am BST on the day of the results with a Q&A session.
For more details or to attend the briefing, please contact optimahealth@icrinc.com
Enquiries
Optima Health
Jonathan Thomas, CEO
Andrew Bones, Interim CFO
+44(0) 33 0008 5113
media@OptimaHealth.co.uk
Nominated Adviser and Joint Corporate Broker
Panmure Liberum Limited
Emma Earl / Will Goode/ Mark Rogers /
Rupert Dearden
+44 (0)20 3100 2000
Joint Corporate Broker
Cavendish Capital Markets
Geoff Nash / Ben Jeynes / George Lawson /
Julian Morse / Michael Johnson/ Nigel Birks
+ 44 (0)20 7220 0500
UK Financial PR Adviser
ICR Healthcare
Mary-Jane Elliott / Chris Welsh / Lindsey Neville
optimahealth@icrinc.com
About Optima Health
Optima Health is the UK's leading provider of occupational health and wellbeing services, delivering clinically led, technology-driven solutions to organisations across the public and private sectors. With a team of more than 2,000 including 1,250 clinicians, Optima Health supports millions of employees and operates from a network of more than 50 clinics nationwide.
In addition to its core UK market, Optima Health also operates in Ireland under Optima Health Ireland, providing occupational health services to clients nationwide.
For more information visit www.optimahealth.co.uk
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.ENDNORFLFEATIIAIIR
